NASH: Non-invasive Diagnostic Markers and Imaging
Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Patients With Non-alcoholic Fatty Liver Disease Using Markers and Imaging Techniques
Sponsor: Maastricht University Medical Center
Listed as NCT02717000, this observational or N/A phase trial focuses on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis and remains ongoing. Sponsored by Maastricht University Medical Center, it has been updated 10 times since 2016, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
▶ Show 5 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status · Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Not Yet Recruiting NA
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Maastricht University Medical Center
- Zuyderland Medical Centre
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.